Levels of von Willebrand factor antigen and von Willebrand factor cleaving protease (ADAMTS13) activity predict clinical events in chronic heart failure

Autor: J. Papassotiriou, Tímea Gombos, Jan Kunde, László Cervenak, Veronika Makó, Zoltán Pozsonyi, Jolan Harsfalvi, Zsolt Förhécz, Zoltán Prohászka, Lívia Jánoskuti, Gábor Borgulya
Rok vydání: 2009
Předmět:
Zdroj: Thrombosis and haemostasis. 102(3)
ISSN: 0340-6245
Popis: SummaryDecreased activity of ADAMTS13, the von Willebrand factor (VWF) cleaving protease, was recently reported in cardiovascular diseases and in hepatic failure. Chronic heart failure (CHF) is characterised by abnormalities of left ventricular function accompanied by the failure of the liver and dysregulation of endothelial activation. Therefore, the aim of our study was to measure ADAMTS13 activity in CHF, and determine the prognostic value of VWF and ADAMTS13 on major clinical events in CHF.ADAMTS13 activity (measured by FRETS-VWF73 substrate) was decreased in CHF (n = 152, left ventricular ejection fraction Decreased activity of ADAMTS13 with concomitant high VWF:Ag levels is a significant independent predictor of clinical events in CHF. The levels of the two molecules may integrate the impaired synthetic capacity of the liver and the disturbed endothelial regulation and can therefore be a useful tool to predict clinical events in CHF.
Databáze: OpenAIRE